Abstract
Objectives: Patients with suspected Neutropenic sepsis require rapid antibiotic administration, but despite extensive education, only 67% of patients received antibiotics within 60 minutes.
Methods: A Neutropenic Sepsis Alert Card was created, as a Patient Specific Directive - this allows nurses to administer antibiotics to specific patients without prior medical review.
Results: Since the intervention, 301 patients presented with suspected neutropenic sepsis. 277 patients (92%) received their first dose of intravenous antibiotics within 1 hour of arrival into hospital, compared to 95 out of 143 patients (67%) presenting between January and June of 2014 (p=0.036).
Conclusion: The Neutropenic Sepsis Alert Card can significantly improve door to antibiotic needle time for chemotherapy patients with suspected neutropenic sepsis. This intervention is inexpensive and easily replicable in other health care organisations.
[download-attachments container="div" style="list" display_icon="1" display_count="1" display__size="0"]
References
- NCEPOD. For better or worse: A review of the care of patients who died within 30 days of receiving systemic anti-cancer therapy. 2008. Retrieved from http://ncepod.org.uk/2008sact.htm
- Herbst C, Naumann F, Kruse E-B, et al. Prophylactic antibiotics or G-CSF for the prevention of infections and improvement in survival in cancer patients undergoing chemotherapy. Cochrane Database of Systematic Reviews CD007107. 2009.
- Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock. Crit Care Med, 2008; 296-327.
- Gaieski DF, Mikkelsen ME, Band RA , et al. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med 2010; 1045-1053.
- National Chemotherapy Advisory Group Chemotherapy Services in England: Ensuring quality and safety. 2009. Retrieved from http://webarchive.nationalarchives.gov.uk/20130107105354/ http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_104501.pdf
- National Institute of Clinical Excellence. Neutropenic sepsis: prevention and management of neutropenic sepsis in cancer patients. 2012. Retrieved from NICE CG151: https://www.nice.org.uk/guidance/cg151/evidence/cg151-neutropenic-sepsis-fullguideline2
- Clarke, R. Warnick J, Stretton K, et al. Improving the immediate management of neutropenic sepsis in the UK: lessons from a national audit. British Journal of Haematology 2011, 773-779.
- Medicines and Healthcare Products Regulatory Agency. (n.d.). Frequently asked questions: Patient Specific Directions. Retrieved from http://webarchive.
nationalarchives.gov.uk/20141205150130/http:/www.mhra.gov.uk/Howweregulate/Medicines/Availabilityprescribingsellingandsupplyingofmedicines/Frequentlyraisedissues/PatientSpecificDirections/index.htm
Request Permissions
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center’s (CCC) Marketplace website by clicking the button below:
